Document Detail

Keratin 14-Null Cells as a Model to Test the Efficacy of Gene Therapy Approaches in Epithelial Cells.
MedLine Citation:
PMID:  21326298     Owner:  NLM     Status:  Publisher    
Skin fragility disorders caused by keratin mutations are incurable, and a better understanding of their etiology is needed to find new ways to improve and treat these conditions. The best-studied skin fragility disorder is epidermolysis bullosa simplex (EBS), an autosomal dominant condition caused by mutations in keratin 5 (K5) or K14. To analyze disease mechanisms and develop gene therapy strategies, we have used keratinocyte cell lines derived from EBS patients as model systems. Here, we describe two cell lines established from EBS patients with K14-null mutations. We analyze the responses of these cells to stress assays previously shown to discriminate between wild-type and keratin-mutant keratinocytes, to directly evaluate the efficacy of rescuing K14-null cells by supplementation with wild-type K14 complementary DNA (cDNA). The K14-null cells show elevated levels of stress correlating with reduced normal keratin function. By transfecting wild-type K14 into these cells, we demonstrate "proof of principle" that an add-back approach can significantly rescue the normal keratinocyte behavior profile. These K14-null cell lines provide a disease model for studying the effects of keratin ablation in EBS patients and to test the efficacy of gene add-back and other therapy approaches in keratinocytes.Journal of Investigative Dermatology advance online publication, 17 February 2011; doi:10.1038/jid.2011.19.
Mariella D'Alessandro; Stephanie E Coats; Marcel F Jonkmann; Irene M Leigh; E Birgitte Lane
Related Documents :
6605998 - Cell surface expression of cytotoxic t lymphocyte-defined, akr/gross leukemia virus-ass...
20687788 - Plasmodesmata: gateways to local and systemic virus infection.
12202208 - Azathioprine inhibits vaccinia virus replication in both bsc-40 and rag cell lines acti...
10494498 - Inter-laboratory comparison of cell lines for susceptibility to three viruses: vhsv, ih...
25127868 - Synthesis and evaluation of novel alkannin and shikonin oxime derivatives as potent ant...
22749958 - A new model for myxosporean (myxozoa) development explains the endogenous budding pheno...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-2-17
Journal Detail:
Title:  The Journal of investigative dermatology     Volume:  -     ISSN:  1523-1747     ISO Abbreviation:  -     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-2-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0426720     Medline TA:  J Invest Dermatol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
CR UK Cell Structure Research Group, Division of Molecular Medicine, College of Life Sciences, University of Dundee, Dundee, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  BRAF exon 15 T1799A mutation is common in melanocytic nevi, but less prevalent in cutaneous malignan...
Next Document:  Fibronectin Potentiates Topical Erythropoietin-Induced Wound Repair in Diabetic Mice.